FLEROXACIN

SynDRA canonical compound SYN0000018 — structure-anchored drug synonym record

Clinical phase	Launched
Primary target(s)	TOP2A
Mechanism of action	topoisomerase inhibitor
Indication	diarrhea \| enteritis \| gonorrhea \| respiratory tract infections
Disease area	gastroenterology \| infectious disease

All known targets

flerofloxacin
megalocin
megalone
quinodis
Fleroxacine
Fleroxacino
Megalocin
AM-833
RO-23-6240/000
RO-236240
RO-236240000
Megalone
FLRX
Fleroxacinum
Fleroxicin
Megalosin
Quinodis
Fleroxacine [French]
Fleroxacino [Spanish]
Fleroxacinum [Latin]
F0646
Megalocin (TN)
Megalone (TN)
Quinodis (TN)
Ro 23-6240
Ro-236240
Ro-23-6240/000
Fleroxacin (JAN/USAN/INN)
Fleroxacin [USAN:BAN:INN:JAN]
6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methylpiperazino)-4-oxo-3-quinolinecarboxylic acid
6,8-Difluoro-1-(2-fluoroethyl)1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
6,8-difluoro-1-(2-fluoroethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid-
AM 833
Fleroxacin (Quinodis)
CHEBI:31810